Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Donepezil Patch in Healthy Males
NCT02178124Phase 1Completed
- Sponsor
- Icure Pharmaceutical Inc.
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Icure Pharmaceutical Inc. Primary endpoint: Safety and Tolerability Evaluation. Started Jul 2014; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02178124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178124.